7月 2026
- 首頁
- NEUROPHET
7月 2026NEUROPHET的市場佔有率分析
Founded in 2016, Neurophet is a specialized company dedicated to researching and developing AI technology-based brain imaging analysis solutions and therapeutic medical devices across the entire cycle of "diagnosis, treatment guidance, and treatment." Under the mission of The Pioneer of Brain Frontiers, Neurophet continues its journey to become a global Pioneer in AI-Driven Diagnosis and Treatment of Brain Disorders.
NEUROPHET(包含公司地區)
查看更多網站流量與參與度資訊- neurophet.com
NEUROPHET的熱門網域總造訪量
了解NEUROPHET市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
NEUROPHET的熱門網域平均造訪時長
分析NEUROPHET參與度指標。
過去 3 個月平均造訪時長
子公司細目
NEUROPHET的熱門網域平均頁面瀏覽量
了解NEUROPHET如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自NEUROPHET
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Neurophet signed new client Raffles Medical Group on Jul 14th '26.* Raffles Medical has signed Neurophet to supply AQUA, an AI-powered neurodegenerative brain-imaging analysis software, for its network of private hospitals.
7月 14, 2026閱讀更多
新聞NEUROPHET, Inc. is developing AI algorithms on Jun 23rd '26.Based on these datasets, Neurophet will develop and validate AI algorithms.
6月 23, 2026閱讀更多
新聞NEUROPHET, Inc. attended event BIO USA on Jun 22nd '26.Neurophet showcases 'brain imaging AI solutions' at BIO USA, accelerates global business development collaborations.
6月 16, 2026閱讀更多
查看所有NEUROPHET信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
